152 related articles for article (PubMed ID: 10508799)
1. Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol.
Dhand R; Goode M; Reid R; Fink JB; Fahey PJ; Tobin MJ
Am J Respir Crit Care Med; 1999 Oct; 160(4):1136-41. PubMed ID: 10508799
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers.
Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
J Clin Pharmacol; 1998 Dec; 38(12):1096-106. PubMed ID: 11301561
[TBL] [Abstract][Full Text] [Related]
3. Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man--no evidence of enantioselective lung metabolism.
Ward JK; Dow J; Dallow N; Eynott P; Milleri S; Ventresca GP
Br J Clin Pharmacol; 2000 Jan; 49(1):15-22. PubMed ID: 10606833
[TBL] [Abstract][Full Text] [Related]
4. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
Tripp K; McVicar WK; Nair P; Corren J; Pleskow WW; Goodwin E; Baumgartner RA; Hanrahan JP
J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of levosalbutamol: what are the clinical implications?
Boulton DW; Fawcett JP
Clin Pharmacokinet; 2001 Jan; 40(1):23-40. PubMed ID: 11236808
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
[TBL] [Abstract][Full Text] [Related]
7. The correlation of urinary levels of albuterol and its metabolites isomers following inhalation from a dry powder inhaler and in vitro particle size characterisation.
Srichana T; Suedee R; Tanmanee N; Muanpanarai D; Marriott C
Pulm Pharmacol Ther; 2007; 20(1):36-45. PubMed ID: 16325440
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma.
Maier G; Rubino C; Hsu R; Grasela T; Baumgartner RA
Pulm Pharmacol Ther; 2007; 20(5):534-42. PubMed ID: 16891136
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle.
Jacobson GA; Yee KC; Premilovac D; Rattigan S
Drug Test Anal; 2014 Jun; 6(6):563-7. PubMed ID: 24574331
[TBL] [Abstract][Full Text] [Related]
10. Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser.
Silkstone VL; Corlett SA; Chrystyn H
Eur J Clin Pharmacol; 2002 Jan; 57(11):781-6. PubMed ID: 11868799
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects.
Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
Pulm Pharmacol Ther; 1999; 12(6):353-62. PubMed ID: 10587476
[TBL] [Abstract][Full Text] [Related]
12. A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit.
Ballard J; Lugo RA; Salyer JW
Respir Care; 2002 Jan; 47(1):31-8. PubMed ID: 11749685
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients.
Lötvall J; Palmqvist M; Arvidsson P; Maloney A; Ventresca GP; Ward J
J Allergy Clin Immunol; 2001 Nov; 108(5):726-31. PubMed ID: 11692096
[TBL] [Abstract][Full Text] [Related]
14. Inhaled beta agonists.
Op't Holt TB
Respir Care; 2007 Jul; 52(7):820-32. PubMed ID: 17594727
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of (R,S)-Albuterol after aerosol inhalation in healthy adult volunteers.
Anderson PJ; Zhou X; Breen P; Gann L; Logsdon TW; Compadre CM; Hiller FC
J Pharm Sci; 1998 Jul; 87(7):841-4. PubMed ID: 9649352
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective pharmacokinetics of S-salbutamol after administration of the racemate in healthy volunteers.
Schmekel B; Rydberg I; Norlander B; Sjöswärd KN; Ahlner J; Andersson RG
Eur Respir J; 1999 Jun; 13(6):1230-5. PubMed ID: 10445595
[TBL] [Abstract][Full Text] [Related]
17. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
Handley D
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.
Silkstone VL; Tomlinson HS; Corlett SA; Chrystyn H
Br J Clin Pharmacol; 2000 Sep; 50(3):281-4. PubMed ID: 10971315
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
20. Serum albuterol levels in mechanically ventilated patients and healthy subjects after metered-dose inhaler administration.
Duarte AG; Dhand R; Reid R; Fink JB; Fahey PJ; Tobin MJ; Jenne JW
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1658-63. PubMed ID: 8970351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
